Skip to main content
CTVA
NYSE Life Sciences

Corteva Warns Brazil Deterioration Persists, Inventory Overhang to Hit Q4

Tom Rudovsky · Reported by Reuters
More coverage: Healthcare
Sentiment info
Negative
Importance info
8
Price
$9.815
Mkt Cap
$6.55B
52W Low
$9.14
52W High
$14.62
52W Position info
7.4% above low
Off High info
33% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

CTVA is trading near its 52-week low of $9.14 (7.4% above the low).

Summary

On the Q3 call, management said Brazil conditions deteriorated sharply in the final weeks of the quarter and the negative trend is continuing. Corteva entered 2026 carrying more of its own inventory in the channel than expected, and it is not assuming any meaningful improvement in Brazilian purchasing behavior for the rest of the year. That inventory will weigh on Q4 results, though the company expects levels to normalize by the end of the growing season. Cost actions are already underway: a hiring freeze is in place and certain R&D projects are being shelved for a year. Management is refusing to extend payment terms or offer credit to past-due Brazil distributors, and the CEO expects a return to growth in 2027, with 2H27 outperforming 2H26 if the inventory overhang clears. This follows yesterday's Q3 loss of $54 million, or $0.08 a share, on a 9% sales decline to $1.59 billion and the FY26 EBITDA guidance cut disclosed in today's 8-K.

At the time of this announcement, CTVA was trading at $9.82 on NYSE in the Life Sciences sector, with a market capitalization of approximately $6.5B. The 52-week trading range was $9.14 to $14.62. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

CTVA - Latest Insights

CTVA
Nov 12, 2026, 8:34 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $10.89
Real-time Price: $9.39 info
Change: -$1.50 (-14%) info
Market Cap: $6.263B info
CTVA
Nov 12, 2026, 5:45 AM EST
Source: Benzinga
Importance Score:
8
Price at Filing: $10.89
Real-time Price: $9.39 info
Change: -$1.51 (-14%) info
Market Cap: $6.263B info
CTVA
Nov 11, 2026, 4:30 PM EST
Source: PR Newswire
Importance Score:
8
Price at Filing: $12.19
Real-time Price: $9.39 info
Change: -$2.80 (-23%) info
Market Cap: $6.263B info
CTVA
Nov 10, 2026, 5:49 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $12.13
Real-time Price: $9.39 info
Change: -$2.75 (-23%) info
Market Cap: $6.263B info
CTVA
Oct 13, 2026, 6:30 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $13.25
Real-time Price: $9.39 info
Change: -$3.87 (-29%) info
Market Cap: $6.263B info